Sonpiretigene isteparvovec

N/A

Report date: 2023/10/26 17:03:04

Base Information

Drug NameSonpiretigene isteparvovec

Drug Alias NameMCO-010vMCO-1vMCO-010

ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector > AAV2 vector

Mechanisms of ActionEye protein replacements

TargetsEye proteins

Therapy Area/IndicationsRetinitisRetinal DystrophiesRetinal Diseases +[8]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesPuerto Rico

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsRetinitisRetinal DystrophiesRetinal Diseases +[7]

Inactive IndicationsEye Diseases

ATC CodeN/A